The REDUSE Trial is funded by The Swedish Research Council

Nov 30, 2023
1 min read

Updated: Jan 11, 2024

We are very pleased to announce that the Swedish Research Council (Vetenskapsrådet) has granted the REDUSE Trial a total of 19.3 MSEK over the period 2024 - 2027.

Recent Posts

See All

REDUSE hits 50% of patient recruitment target

(June 15) Last month, the REDUSE trial passed a significant milestone by reaching 50% of its target for patient inclusion. This major threshold is an exciting development, as it reflects the interest

Patient recruitment for REDUSE begins in Tampere, Finland

(May 25) Tammerfors University Hospital (Tays) in Tampere, Finland, became the second international site to commence patient recruitment for the REDUSE study. This exciting development comes just seve

Thesis defended by another REDUSE team member, Linn Hemberg

(March 31) Linn Hemberg, an environmental science researcher in perioperative and intensive care, defended her thesis, "Critical Care, Critical Emissions: Applying life cycle assessment on intensive a

Comments